Myocardial ischemia, reperfusion, and infarction in chronically instrumented, intact, conscious, and unrestrained mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 302, Issue 12, 2012, Pages

  Lujan, Heidi L ^a   Janbaih, Hussein ^a   Feng, Han Zhong ^a   Jin, Jian Ping ^a   DiCarlo, Stephen E ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Electrocardiogram; Histological sections; Photomicrographs

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONSCIOUSNESS; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; INSTRUMENTATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CONSCIOUSNESS; DISEASE MODELS, ANIMAL; HEART; MICE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIUM;

EID: 84862683442     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00095.2012     Document Type: Article

References (115)

1. Albert MA. The role of C-reactive protein in cardiovascular disease risk. Curr Cardiol Rep 2: 274-279, 2000.
2. Albert MA, Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation 108: 161-165, 2003.
3. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 110: 588-636, 2004.
4. Aronow Silent MIWS. Prevalence and prognosis in older patients diagnosed by routine electrocardiograms. Geriatrics 58: 24-28, 40, 2003.
5. Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Munzel T, Simoons ML, Hamm CW. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108: 1440-1445, 2003.
6. Barron HV, Bowlby LJ, Breen T, Rogers WJ, Canto JG, Zhang Y, Tiefenbrunn AJ, Weaver WD. Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. Circulation 97: 1150-1156, 1998.
7. Barsotti A, Di NP, Dini FL, Soccio M, Di IP, Gallina S, Di MM, Modesti A. Effect of acute increase of interstitial myocardial fluid on ventricular function in isolated working rat hearts. J Med 29: 137-158, 1998.
8. Beck-Schimmer B, Breitenstein S, Urech S, De CE, Wittlinger M, Puhan M, Jochum W, Spahn DR, Graf R, Clavien PA. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg 248: 909-918, 2008.
9. Bergmann SR, Clark RE, Sobel BE. An improved isolated heart preparation for external assessment of myocardial metabolism. Am J Physiol Heart Circ Physiol 236: H644-H661, 1979.
10. Berul CI. Electrophysiological phenotyping in genetically engineered mice. Physiol Genomics 13: 207-216, 2003.
11. Billman GE. Cardiac autonomic neural remodeling and susceptibility to sudden cardiac death: effect of endurance exercise training. Am J Physiol Heart Circ Physiol 297: H1171-H1193, 2009.
12. Braunwald E, Kim CB. Late establishment of patency of the infarct-related artery. In: Management of Acute Myocardial Infarction, edited by Julian D and Braunwald E. Philadelphia, PA: Saunders, 1994.
13. Braunwald E, Kloner RA. Myocardial reperfusion: a double-edged sword? J Clin Invest 76: 1713-1719, 1985.
14. Brennan ML, Penn MS, Van LF, Nambi V, Shishehbor MH, Aviles RJ, Goormastic M, Pepoy ML, McErlean ES, Topol EJ, Nissen SE, Hazen SL. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349: 1595-1604, 2003.
15. Chandrasekar B, Mitchell DH, Colston JT, Freeman GL. Regulation of CCAAT/Enhancer binding protein, interleukin-6, interleukin-6 receptor, and gp130 expression during myocardial ischemia/reperfusion. Circulation 99: 427-433, 1999.
16. Chen CY, DiCarlo SE. Daily exercise and gender influence arterial baroreflex regulation of heart rate and nerve activity. Am J Physiol Heart Circ Physiol 271: H1840-H1848, 1996.
17. Chen CY, DiCarlo SE, Scislo TJ. Daily spontaneous running attenuated the central gain of the arterial baroreflex. Am J Physiol Heart Circ Physiol 268: H662-H669, 1995.
18. Cohn PF, Fox KM, Daly C. Silent myocardial ischemia. Circulation 108: 1263-1277, 2003.
19. Collins HL, DiCarlo SE. Acute exercise increases the ventricular arrhythmia threshold via the intrinsic adenosine receptor system in conscious hypertensive rats. Am J Physiol Heart Circ Physiol 289: H1020-H1026, 2005.
20. Cope DK, Impastato WK, Cohen MV, Downey JM. Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthe-siology 86: 699-709, 1997.
21. Cozzi E, Hazarika S, Stallings HW, Cascio WE, Devlin RB, Lust RM, Wingard CJ, Van Scott MR. Ultrafine particulate matter exposure augments ischemia-reperfusion injury in mice. Am J Physiol Heart Circ Physiol 291: H894-H903, 2006.
22. De Hert SG, Turani F, Mathur S, Stowe DF. Cardioprotection with volatile anesthetics: mechanisms and clinical implications. Anesth Analg 100: 1584-1593, 2005.
23. Deng Q, Scicli AG, Lawton C, Silverman NA. Coronary flow reserve after ischemia and reperfusion of the isolated heart. Divergent results with crystalloid versus blood perfusion. J Thorac Cardiovasc Surg 109: 466-472, 1995.
24. DiCarlo SE, Chen CY, Collins HL. Onset of exercise increases lumbar sympathetic nerve activity in rats. Med Sci Sports Exerc 28: 677-684, 1996.
25. Domanski MJ, Mahaffey K, Hasselblad V, Brener SJ, Smith PK, Hillis G, Engoren M, Alexander JH, Levy JH, Chaitman BR, Brod-erick S, Mack MJ, Pieper KS, Farkouh ME. Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA 305: 585-591, 2011.
26. Drici MD, Arrighi I, Chouabe C, Mann JR, Lazdunski M, Romey G, Barhanin J. Involvement of IsK-associated K+ channel in heart rate control of repolarization in a murine engineered model of Jervell and Lange-Nielsen syndrome. Circ Res 83: 95-102, 1998.
27. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 53: 31-47, 2002.
28. Friedman BJ, Grinberg OY, Grinberg SA, Swartz HM. Myocardial oxygen tension in isolated erythrocyte-perfused rat hearts and comparison with crystalloid media. J Mol Cell Cardiol 29: 2855-2858, 1997.
29. Geisterfer-Lowrance AA, Christe M, Conner DA, Ingwall JS, Schoen FJ, Seidman CE, Seidman JG. A mouse model of familial hypertrophic cardiomyopathy. Science 272: 731-734, 1996.
30. Gottlieb SO, Gottlieb SH, Achuff SC, Baumgardner R, Mellits ED, Weisfeldt ML, Gerstenblith G. Silent ischemia on Holter monitoring predicts mortality in high-risk postinfarction patients. JAMA 259: 1030-1035, 1988.
31. Gourbal BE, Barthelemy M, Petit G, Gabrion C. Spectrographic analysis of the ultrasonic vocalisations of adult male and female BALB/c mice. Naturwissenschaften 91: 381-385, 2004.
32. Gutterman DD. Silent myocardial ischemia. Circ J 73: 785-797, 2009.
33. Haack B, Markl H, Ehret G. Sound Communication between parents and offspring. In: The Auditory Psychobiology of the Mouse, edited by Willott J. Springfield, IL: Thomas, 1983.
34. Haessler R, Kuzume K, Chien GL, Wolff RA, Davis RF, Van Winkle DM. Anaesthetics alter the magnitude of infarct limitation by ischaemic preconditioning. Cardiovasc Res 28: 1574-1580, 1994.
35. Hagendorff A, Schumacher B, Kirchhoff S, Luderitz B, Willecke K. Conduction disturbances and increased atrial vulnerability in Con-nexin40-deficient mice analyzed by transesophageal stimulation. Circulation 99: 1508-1515, 1999.
36. Halliwill JR, Billman GE. Effect of general anesthesia on cardiac vagal tone. Am J Physiol Heart Circ Physiol 262: H1719-H1724, 1992.
37. Hartley CJ, Taffet GE, Reddy AK, Entman ML, Michael LH. Noninvasive cardiovascular phenotyping in mice. ILAR J 43: 147-158, 2002.
38. Hazarika S, Van Scott MR, Lust RM. Severity of myocardial injury following ischemia-reperfusion is increased in a mouse model of allergic asthma. Am J Physiol Heart Circ Physiol 292: H572-H579, 2007.
39. Hearse DJ, Bolli R. Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc Res 26: 101-108, 1992.
40. Hochman JS, Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 75: 299-306, 1987.
41. Janse MJ, Opthof T, Kleber AG. Animal models of cardiac arrhythmias. Cardiovasc Res 39: 165-77, 1998.
42. Janssen PM. Challenges in cardiac muscle physiology. Front Physiol 1: 2, 2010.
43. Julier K, da SR, Garcia C, Bestmann L, Frascarolo P, Zollinger A, Chassot PG, Schmid ER, Turina MI, von Segesser LK, Pasch T, Spahn DR, Zaugg M. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multi-center study. Anesthesiology 98: 1315-1327, 2003.
44. Kaiser Air pollution J. Evidence mounts that tiny particles can kill. Science 289: 22-23, 2000.
45. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med 311: 1144-1147, 1984.
46. Kanno S, Lerner DL, Schuessler RB, Betsuyaku T, Yamada KA, Saffitz JE, Kovacs A. Echocardiographic evaluation of ventricular remodeling in a mouse model of myocardial infarction. J Am Soc Echocardiogr 15: 601-609, 2002.
47. Kapinya KJ, Lowl D, Futterer C, Maurer M, Waschke KF, Isaev NK, Dirnagl U. Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke 33: 1889-1898, 2002.
48. Kasahara H, Wakimoto H, Liu M, Maguire CT, Converso KL, Shioi T, Huang WY, Manning WJ, Paul D, Lawitts J, Berul CI, Izumo S. Progressive atrioventricular conduction defects and heart failure in mice expressing a mutant Csx/Nkx2.5 homeoprotein. J Clin Invest 108: 189-201, 2001.
49. Kim CB, Braunwald E. Potential benefits of late reperfusion of in-farcted myocardium. The open artery hypothesis. Circulation 88: 2426-2436, 1993.
50. Krantz DS, Hedges SM, Gabbay FH, Klein J, Falconer JJ, Merz CN, Gottdiener JS, Lutz H, Rozanski A. Triggers of angina and ST-segment depression in ambulatory patients with coronary artery disease: evidence for an uncoupling of angina and ischemia. Am Heart J 128: 703-712, 1994.
51. Kudo M, Wang Y, Wani MA, Xu M, Ayub A, Ashraf M. Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. J Mol Cell Cardiol 35: 1113-1119, 2003.
52. Lal A, Veinot JP, Ganten D, Leenen FH. Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogen. J Mol Cell Cardiol 39: 521-529, 2005.
53. Lamas GA, Flaker GC, Mitchell G, Smith SC Jr, Gersh BJ, Wun CC, Moye L, Rouleau JL, Rutherford JD, Pfeffer MA. Effect of infarct artery patency on prognosis after acute myocardial infarction The Survival and Ventricular Enlargement Investigators. Circulation 92: 1101-1109, 1995.
54. Lefer DJ, Bolli R. Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitation. J Cardiovasc Pharmacol Ther 16: 332-339, 2011.
55. Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 75: S715-S720, 2003.
56. Liu R, Ishibe Y, Ueda M. Isoflurane-sevoflurane adminstration before ischemia attenuates ischemia-reperfusion-induced injury in isolated rat lungs. Anesthesiology 92: 833-840, 2000.
57. London B, Jeron A, Zhou J, Buckett P, Han X, Mitchell GF, Koren G. Long QT and ventricular arrhythmias in transgenic mice expressing the N terminus and first transmembrane segment of a voltage-gated potassium channel. Proc Natl Acad Sci USA 95: 2926-2931, 1998.
58. Lucchinetti E, Jamnicki M, Fischer G, Zaugg M. Preconditioning by isoflurane retains its protection against ischemia-reperfusion injury in postinfarct remodeled rat hearts. Anesth Analg 106: 17-23, table, 2008.
59. Lujan HL, Britton SL, Koch LG, DiCarlo SE. Reduced susceptibility to ventricular tachyarrhythmias in rats selectively bred for high aerobic capacity. Am J Physiol Heart Circ Physiol 291: H2933-H2941, 2006.
60. Lujan HL, Chen Y, DiCarlo SE. Paraplegia increased cardiac NGF content, sympathetic tonus and the susceptibility to ischemia-induced ventricular tachycardia in conscious rats. Am J Physiol Heart Circ Physiol 296: H1364-H1372, 2009.
61. Lujan HL, DiCarlo SE. T5 spinal cord transection increases susceptibility to reperfusion-induced ventricular tachycardia by enhancing sympathetic activity in conscious rats. Am J Physiol Heart Circ Physiol 293: H3333-H3339, 2007.
62. Lujan HL, DiCarlo SE. Sex differences to myocardial ischemia and pj-adrenergic receptor blockade in conscious rats. Am J Physiol Heart Circ Physiol 294: H1523-H1529, 2008.
63. Lujan HL, DiCarlo SE. Partial hindlimb occlusion reduced the susceptibility to sustained ventricular tachycardia in conscious rats. J Cardiovasc Pharmacol Ther 14: 199-206, 2009.
64. Lujan HL, Kramer VA, DiCarlo SE. Electro-acupuncture decreases the susceptibility to ventricular tachycardia in conscious rats by reducing cardiac metabolic demand. Am J Physiol Heart Circ Physiol 292: H2550-H2555, 2007.
65. Lujan HL, Kramer VJ, DiCarlo SE. Sex influences the susceptibility to reperfusion-induced sustained ventricular tachycardia and fj-adrenergic receptor blockade in conscious rats. Am J Physiol Heart Circ Physiol 293: H2799-H2808, 2007.
66. Lujan HL, Krishnan S, DiCarlo SE. Cardiac spinal deafferentation reduces the susceptibility to sustained ventricular tachycardia in conscious rats. Am J Physiol Regul Integr Comp Physiol 301: R775-R782, 2011.
67. Lujan HL, Palani G, Zhang L, DiCarlo SE. Targeted ablation of cardiac sympathetic neurons reduces the susceptibility to ischemia-induced sustained ventricular tachycardia in conscious rats. Am J Physiol Heart Circ Physiol 298: H1330-H1339, 2010.
68. Lutgens E, Daemen MJ, de Muinck ED, Debets J, Leenders P, Smits JF. Chronic myocardial infarction in the mouse: cardiac structural and functional changes. Cardiovasc Res 41: 586-593, 1999.
69. Meiltz A, Ciaroni S. Silent myocardial ischaemia: a deafening silence. Rev Med Suisse Romande 1: 613-616, 2005.
70. Michael LH, Ballantyne CM, Zachariah JP, Gould KE, Pocius JS, Taffet GE, Hartley CJ, Pham TT, Daniel SL, Funk E, Entman ML. Myocardial infarction and remodeling in mice: effect of reperfusion. Am J Physiol Heart Circ Physiol 277: H660-H668, 1999.
71. Michael LH, Hunt JR, Weilbaecher D, Perryman MB, Roberts R, Lewis RM, Entman ML. Creatine kinase and phosphorylase in cardiac lymph: coronary occlusion and reperfusion. Am J Physiol Heart Circ Physiol 248: H350-H359, 1985.
72. Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ, Gibbons RJ. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation 92: 334-341, 1995.
73. Nossuli TO, Lakshminarayanan V, Baumgarten G, Taffet GE, Bal-lantyne CM, Michael LH, Entman ML. A chronic mouse model of myocardial ischemia-reperfusion: essential in cytokine studies. Am J Physiol Heart Circ Physiol 278: H1049-H1055, 2000.
74. Opie LH. Reperfusion injury and its pharmacologic modification. Circulation 80: 1049-1062, 1989.
75. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705, 2001.
76. Park SW, Lee SY, Park SJ, Lee SC, Gwon HC, Kim DK. Quantitative assessment of infarct size in vivo by myocardial contrast echocardiog-raphy in a murine acute myocardial infarction model. Int J Cardiol 97: 393-398, 2004.
77. Patten RD, Aronovitz MJ, ras-Mejia L, Pandian NG, Hanak GG, Smith JJ, Mendelsohn ME, Konstam MA. Ventricular remodeling in a mouse model of myocardial infarction. Am J Physiol Heart Circ Physiol 274: H1812-H1820, 1998.
78. Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E. Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol Heart Circ Physiol 260: H1406-H1414, 1991.
79. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81: 1161-1172, 1990.
80. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E. Myocardial infarct size and ventricular function in rats. Circ Res 44: 503-512, 1979.
81. Piot CA, Padmanaban D, Ursell PC, Sievers RE, Wolfe CL. Ischemic preconditioning decreases apoptosis in rat hearts in vivo. Circulation 96: 1598-1604, 1997.
82. Pravdic D, Sedlic F, Mio Y, Vladic N, Bienengraeber M, Bosnjak ZJ. Anesthetic-induced preconditioning delays opening of mitochondrial permeability transition pore via protein Kinase C-epsilon-mediated pathway. Anesthesiology 111: 267-274, 2009.
83. Qiu Y, Hearse DJ. Comparison of ischemic vulnerability and responsiveness to cardioplegic protection in crystalloid-perfused versus blood-perfused hearts. J Thorac Cardiovasc Surg 103: 960-968, 1992.
84. Reaume AG, de Sousa PA, Kulkarni S, Langille BL, Zhu D, Davies TC, Juneja SC, Kidder GM, Rossant J. Cardiac malformation in neonatal mice lacking connexin43. Science 267: 1831-1834, 1995.
85. Reed MD, Gigliotti AP, McDonald JD, Seagrave JC, Seilkop SK, Mauderly JL. Health effects of subchronic exposure to environmental levels of diesel exhaust. Inhal Toxicol 16: 177-193, 2004.
86. Ridker PM. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. Am Heart J 148: S19-S26, 2004.
87. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, De SG, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123: e18-e209, 2011
88. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB. Heart Disease and Stroke Statistics-2012 Update: A Report From the American Heart Association. Circulation 125: e2-e220, 2012.
89. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel BJ, Russell RO, Smith EE Jr, Weaver WD. ACC/AHA guidelines for the management of patients with acute myocardial infarction A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 28: 1328-1428, 1996.
90. Sales GD. Ultrasound and aggressive behaviour in rats and other small mammals. Anim Behav 20: 88-100, 1972.
91. Sanchez O, Arnau A, Pareja M, Poch E, Ramirez I, Soley M. Acute stress-induced tissue injury in mice: differences between emotional and social stress. Cell Stress Chaperones 7: 36-46, 2002.
92. Schaper W, Winkler B. Of mice and men-the future of cardiovascular research in the molecular era. Cardiovasc Res 39: 3-7, 1998.
93. Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, Moak JP, Maron BJ, Seidman CE, Seidman JG. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281: 108-111, 1998.
94. Schwartz LL, Kloner RA, Arai AE, Baines CP, Bolli R, Braunwald E, Downey J, Gibbons RJ, Gottlieb RA, Heusch G, Jennings RB, Lefer DJ, Mentzer RM, Murphy E, Ovize M, Ping P, Przyklenk K, Sack MN, Vander Heide RS, Vinten-Johansen J, Yellon DM. New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation 124: 1172-1179, 2011.
95. Scislo TJ, DiCarlo SE. Gender difference in cardiopulmonary reflex inhibition of sympathetic nerve activity. Am J Physiol Heart Circ Physiol 267: H1537-H1543, 1994.
96. Simon AM, Goodenough DA, Paul DL. Mice lacking connexin40 have cardiac conduction abnormalities characteristic of atrioventricular block and bundle branch block. Curr Biol 8: 295-298, 1998.
97. Sipos ML, Kerchner M, Nyby JG. An ephemeral sex pheromone in the urine of female house mice (Mus domesticus). Behav Neural Biol 58: 138-143, 1992.
98. Sloan RC, Rosenbaum M, O'Rourke D, Oppelt K, Frasier CR, Waston CA, Allan AG, Brown DA. High doses of ketamine-xylazine anesthesia reduce cardiac ischemia-reperfusion injury in guinea pigs. J Am Assoc Lab Anim Sci 50: 349-354, 2011.
99. Stables CL, Curtis MJ. Development and characterization of a mouse in vitro model of ischaemia-induced ventricular fibrillation. Cardiovasc Res 83: 397-404, 2009.
100. Stadnicka A, Marinovic J, Ljubkovic M, Bienengraeber MW, Bos-njak ZJ. Volatile anesthetic-induced cardiac preconditioning. J Anesth 21: 212-219, 2007.
101. Stowers L, Holy TE, Meister M, Dulac C, Koentges G. Loss of sex discrimination and male-male aggression in mice deficient for TRP2. Science 295: 1493-1500, 2002.
102. Swoap SJ, Overton JM, Garber G. Effect of ambient temperature on cardiovascular parameters in rats and mice: a comparative approach. Am J Physiol Regul Integr Comp Physiol 287: R391-R396, 2004.
103. Takagawa J, Zhang Y, Wong ML, Sievers RE, Kapasi NK, Wang Y, Yeghiazarians Y, Lee RJ, Grossman W, Springer ML. Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches. J Appl Physiol 102: 2104-2111, 2007.
104. Virag JI, Murry CE. Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. Am J Pathol 163: 2433-2440, 2003.
105. Walsh RS, Tsuchida A, Daly JJ, Thornton JD, Cohen MV, Downey JM. Ketamine-xylazine anaesthesia permits a KATP channel antagonist to attenuate preconditioning in rabbit myocardium. Cardiovasc Res 28: 1337-1341, 1994.
106. Wang C, Jin LJ, Jung HH, Zuo Z. Pretreatment with volatile anesthetics, but not with the nonimmobilizer 1,2-dichlorohexafluorocyclobu-tane, reduced cell injury in rat cerebellar slices after an in vitro simulated ischemia. Brain Res 1152: 201-208, 2007.
107. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, An P, Antonarakis SE, Attwood J, Baertsch R, Bailey J, Barlow K, Beck S, Berry E, Birren B, Bloom T, Bork P, Botcherby M, Bray N, Brent MR, Brown DG, Brown SD, Bult C, Burton J, Butler J, Campbell RD, Carninci P, Cawley S, Chiaromonte F, Chinwalla AT, Church DM, Clamp M, Clee C, Collins FS, Cook LL, Copley RR, Coulson A, Couronne O, Cuff J, Curwen V, Cutts T, Daly M, David R, Davies J, Delehaunty KD, Deri J, Dermitzakis ET, Dewey C, Dickens NJ, Diekhans M, Dodge S, Dubchak I, Dunn DM, Eddy SR, Elnitski L, Emes RD, Eswara P, Eyras E, Felsenfeld A, Fewell GA, Flicek P, Foley K, Frankel WN, Fulton LA, Fulton RS, Furey TS, Gage D, Gibbs RA, Glusman G, Gnerre S, Goldman N, Goodstadt L, Graf-ham D, Graves TA, Green ED, Gregory S, Guigo R, Guyer M, Hardison RC, Haussler D, Hayashizaki Y, Hillier LW, Hinrichs A, Hlavina W, Holzer T, Hsu F, Hua A, Hubbard T, Hunt A, Jackson I, Jaffe DB, Johnson LS, Jones M, Jones TA, Joy A, Kamal M, Karlsson EK, Karolchik D, Kasprzyk A, Kawai J, Keibler E, Kells C, Kent WJ, Kirby A, Kolbe DL, Korf I, Kucherlapati RS, Kulbokas EJ, Kulp D, Landers T, Leger JP, Leonard S, Letunic I, Levine R, Li J, Li M, Lloyd C, Lucas S, Ma B, Maglott DR, Mardis ER, Matthews L, Mauceli E, Mayer JH, McCarthy M, McCombie WR, McLaren S, McLay K, McPherson JD, Meldrim J, Meredith B, Mesirov JP, Miller W, Miner TL, Mongin E, Montgomery KT, Morgan M, Mott R, Mullikin JC, Muzny DM, Nash WE, Nelson JO, Nhan MN, Nicol R, Ning Z, Nusbaum C, O'Connor MJ, Okazaki Y, Oliver K, Overton-Larty E, Pachter L, Parra G, Pepin KH, Peterson J, Pe-vzner P, Plumb R, Pohl CS, Poliakov A, Ponce TC, Ponting CP, Potter S, Quail M, Reymond A, Roe BA, Roskin KM, Rubin EM, Rust AG, Santos R, Sapojnikov V, Schultz B, Schultz J, Schwartz MS, Schwartz S, Scott C, Seaman S, Searle S, Sharpe T, Sheridan A, Shownkeen R, Sims S, Singer JB, Slater G, Smit A, Smith DR, Spencer B, Stabenau A, Stange-Thomann N, Sugnet C, Suyama M, Tesler G, Thompson J, Torrents D, Trevaskis E, Tromp J, Ucla C, Ureta-Vidal A, Vinson JP, Von Niederhausern AC, Wade CM, Wall M, Weber RJ, Weiss RB, Wendl MC, West AP, Wetterstrand K, Wheeler R, Whelan S, Wierzbowski J, Willey D, Williams S, Wilson RK, Winter E, Worley KC, Wyman D, Yang S, Yang SP, Zdobnov EM, Zody MC, Lander ES. Initial sequencing and comparative analysis of the mouse genome. Nature 420: 520-562, 2002.
108. Welbourn CR, Goldman G, Paterson IS, Valeri CR, Shepro D, Hechtman HB. Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil. Br J Surg 78: 651-655, 1991.
109. Wellenius GA, Coull BA, Godleski JJ, Koutrakis P, Okabe K, Savage ST, Lawrence JE, Murthy GG, Verrier RL. Inhalation of concentrated ambient air particles exacerbates myocardial ischemia in conscious dogs. Environ Health Perspect 111: 402-408, 2003.
110. White HD, Cross DB, Elliott JM, Norris RM, Yee TW. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. Circulation 89: 61-67, 1994.
111. Wysocki CJ, Nyby J, Whitney G, Beauchamp GK, Katz Y. The vomeronasal organ: primary role in mouse chemosensory gender recognition. Physiol Behav 29: 315-327, 1982.
112. Yang Q, Sanbe A, Osinska H, Hewett TE, Klevitsky R, Robbins J. In vivo modeling of myosin binding protein C familial hypertrophic car-diomyopathy. Circ Res 85: 841-847, 1999.
113. Yang Z, Day YJ, Toufektsian MC, Ramos SI, Marshall M, Wang XQ, French BA, Linden J. Infarct-sparing effect of A2A-adenosine receptor activation is due primarily to its action on lymphocytes. Circulation 111: 2190-2197, 2005.
114. Zhao P, Peng L, Li L, Xu X, Zuo Z. Isoflurane preconditioning improves long-term neurologic outcome after hypoxic-ischemic brain injury in neonatal rats. Anesthesiology 107: 963-970, 2007.
115. Zhu B, Sun Y, Sievers RE, Browne AE, Pulukurthy S, Sudhir K, Lee RJ, Chou TM, Chatterjee K, Parmley WW. Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion. J Am Coll Cardiol 35: 787-795, 2000.